Genetic Testing and Counseling Program for Hereditary ATTR (hATTR) Amyloidosis Offered at No Charge - For Providers | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Reference Materials

Genetic Testing and Counseling Program for Hereditary ATTR (hATTR) Amyloidosis Offered at No Charge – For Providers

key information

source: Alnylam Pharmaceuticals, Inc.

year: 2020

summary/abstract:

Consider genetic testing and counseling for your patients; Alnylam Act® provides one option for eligible individuals.
 
What Is Alnylam Act®?
Alnylam Act® is a sponsored, no-charge, third-party genetic testing and counseling program for patients with a family history or suspected diagnosis of hATTR amyloidosis. The Alnylam Act® program was developed to reduce barriers to genetic testing and counseling to help people make more informed decisions about their health.
 
What Genes Are Tested Through Alnylam Act®?
Genetic testing for hATTR amyloidosis can be ordered through a single gene test for the TTR gene or as part of larger panels. The larger panels test for changes in the TTR gene as well as for changes in other genes associated with hereditary conditions that may have overlapping symptoms with hATTR amyloidosis.
 
read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close